Understanding the underlying genetic mutations or variations is crucial for accurate diagnosis and personalized treatment of rare diseases. Therefore, genetic diagnostic programs carry a paramount significance in the field of rare diseases.
Trispera Pharma Solutions is acutely aware of the crucial role played by genetic diagnostics in the rare disease landscape and is committed to organizing the transfer of biological materials to genetic centers abroad to advance genetic research and diagnostics.
Trispera Pharma Solutions organizes the transfer of biological material from centers for clinical and epidemiological studies or diagnostic programs abroad with the approval of ethics committees and the Ministry of Health of Turkiye.
According to the decision published in the Official Gazette on 10 April 2016, only licensed medical laboratories are authorized to send samples abroad for testing purposes. Trispera Pharma Solutions organizes nationwide diagnostic solutions through medical laboratories on behalf of sponsors and/or investigators.